Abstract:Objectives: The objective of this study was to examine the imaging features of hepatic inflammatory pseudotumors (IPTs) associated with IgG4-related and IgG4-unrelated conditions and to enhance the approach toward distinguishing between these two types of IPTs. Methods: A retrospective study was conducted, involving 20 patients diagnosed with hepatic IPTs. Imaging procedures were conducted within a timeframe of 4 weeks prior to hepatectomy or biopsy. The imaging features were then analyzed and compared using chi-squared analysis. Results: Seventeen (81.0%) IPTs were located in the hepatic subcapsular area; six (66.7%) IgG4-related IPTs were distributed around the hepatic hilum; and eleven (91.7%) IgG4-unrelated and three (33.3%) IgG4-related IPTs had unclear boundaries. All lesions exhibited similar characteristics in CT scans, T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and diffusion-weighted imaging (DWI), with the apparent diffusion coefficient (ADC) values slightly higher than the surrounding liver tissue. Delayed hypoenhancement, observed in five cases (55.6%), was exclusively present in IgG4-related IPTs. The remaining IPT lesions displayed progressive enhancement, septal and marginal enhancement, and persistent enhancement. Central enhancement was absent in three IgG4-related IPTs (33.3%) and ten IgG4-unrelated IPTs (83.3%). The duct-penetrating sign was identified in two IgG4-unrelated IPTs (16.7%) and seven IgG4-related IPTs (77.8%). Furthermore, seven patients with IgG4-related IPTs had additional lesions outside the liver. Conclusions: IgG4-related lesions are frequently found in the vicinity of the hepatic hilum; they display the duct-penetrating sign and affect other organs as well. Both groups exhibited progressive or persistent contrast enhancement in typical IPT lesions, but delayed hypoenhancement was only observed in the IgG4-related IPT group. IgG4-unrelated IPT lesions often exhibited indistinct boundaries lacking central enhancement. Critical relevance statement: Differences in imaging features differentiate IgG4-related and -unrelated inflammatory pseudotumors (IPT). IgG4-related lesions are frequently near the hepatic hilum, display duct-penetrating sign, and affect other organs. Only the IgG4-related group demonstrated delayed hypoenhancement. IgG4-unrelated IPT lesions often exhibited indistinct boundaries lacking central enhancement. Key points: Compared with IgG 4-unrelated IPTs, IgG4-related IPTs show delayed hypoenhancement and affect other organs. IgG4-unrelated IPTs have unclear boundaries and lack central enhancement. Improved IPT diagnostic capabilities can help minimize additional, potentially unnecessary, interventions.

The analysis of enhancement pattern of hepatic inflammatory pseudotumor on contrast-enhanced ultrasound

CEUS features of hepatic inflammatory pseudotumor presenting as hyperenhancement in arterial phase

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

The Value of Contrast-Enhanced Ultrasound in Diagnosis of Hepatic Inflammatory Pseudotumor

[Contrast-Enhanced Ultrasonography in Diagnosis of Inflammatory Pseudotumor of Liver].

Value of Contrast-Enhanced Ultrasound and Enhancement Patterns in the Diagnosis of Adrenal Tumors

Enhancement Patterns Of Gastric Carcinoma On Contrast-Enhanced Ultrasonography: Relationship With Clinicopathological Features

Characteristics of imaging in hepatic inflammatory pseudotumors: a comparison between IgG4-related and IgG4-unrelated cases

The analysis of dynamic enhancement pattern of intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Clinical application of contrast-enhanced ultrasound in inflammatory hepatocellular adenoma

The Study of Contrast-enhanced Ultrasound in the Diagnosis of Hepatic Focal Inflammatory Lesions

Contrast-Enhanced Ultrasound Imaging Features of Focal Splenic Tuberculosis

Evaluation Of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns And Influencing Factors

Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound

MRI Features of Hepatic IgG4-related Inflammatory Pseudotumor

Diagnostic value and characterization of contrast enhanced ultrasound for hepatic giant hemangionmas

Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics

Effect of Contrast-Enhanced Ultrasound on Differential Diagnosis of Intrahepatic Cholangiocarcinoma and Arterial Phase Enhanced Hepatic Inflammatory Lesions

Contrast-enhanced Ultrasound (CEUS) for the Diagnosis of Hypoechoic Hepatic Hemangioma in Clinical Practice.

Role of MR in the Differentiation of IgG4-related from Non-Igg4-related Hepatic Inflammatory Pseudotumor